C12N 2810/00
Vectors comprising a targeting moiety
C12N2810/00 (Vectors comprising a targeting moiety) appears on 896 US grants and 1,453 published applications in this corpus.
Search patents in C12N- Granted patents
- 896
- Published applications
- 1,453
- Assignees
- 631
- Inventors
- 2,415
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 6 | 0 |
| 1997 | 4 | 0 |
| 1998 | 10 | 0 |
| 1999 | 25 | 0 |
| 2000 | 16 | 0 |
| 2001 | 26 | 9 |
| 2002 | 25 | 53 |
| 2003 | 30 | 72 |
| 2004 | 23 | 57 |
| 2005 | 17 | 60 |
| 2006 | 25 | 65 |
| 2007 | 24 | 46 |
| 2008 | 21 | 49 |
| 2009 | 23 | 55 |
| 2010 | 24 | 73 |
| 2011 | 16 | 44 |
| 2012 | 27 | 53 |
| 2013 | 24 | 45 |
| 2014 | 62 | 73 |
| 2015 | 47 | 88 |
| 2016 | 35 | 68 |
| 2017 | 59 | 63 |
| 2018 | 54 | 83 |
| 2019 | 55 | 72 |
| 2020 | 44 | 65 |
| 2021 | 27 | 64 |
| 2022 | 28 | 42 |
| 2023 | 38 | 30 |
| 2024 | 36 | 52 |
| 2025 | 27 | 40 |
| 2026 | 15 | 32 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- S. pyogenes CAS9 mutant genes and polypeptides encoded by same1 Sep 2026US 12,723,264 B2Integrated Dna Technologies, Inc.
- Methods and compositions for enhanced protein production in Bacillus cells18 Aug 2026US 12,709,755 B2Danisco US Inc.
- Modified adeno-associated virus vectors and delivery thereof into the central nervous system4 Aug 2026US 12,697,397 B2Coave Therapeutics
- Methods of delivering anionic agents in vivo using non-viral nanoparticle-based delivery systems16 Jun 2026US 12,653,905 B2Nanora Pharma Inc.
- RNA-guided human genome engineering9 Jun 2026US 12,649,928 B2President and Fellows of Harvard College
- Targeting aav capsids, methods of manufacturing and using same8 Oct 2026US 2026/0308615 A1REGENXBIO Inc.
- An aav2-vector variant for targeted transfer of genes3 Sep 2026US 2026/0258448 A1Universitaetsklinikum Hamburg-Eppendorf
- Cell membrane-penetrating peptide for conjugation20 Aug 2026US 2026/0242827 A1AGC Inc.
- Methods and Systems for Rapid Engineering of Resting Cells13 Aug 2026US 2026/0234558 A1Cellfe, Inc.
- Nuclear Targeted DNA Delivery and Compositions for Use in Practicing the Same13 Aug 2026US 2026/0234655 A1Seawolf Therapeutics, Inc.
Most cited
By later US patents
- Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation489US 8,865,406 B2Massachusetts Institute of Technology · 2014
- Engineering of systems, methods and optimized guide compositions for sequence manipulation480US 8,906,616 B2Massachusetts Institute of Technology · 2014
- Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation451US 8,889,418 B2Massachusetts Institute of Technology · 2014
- Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation422US 8,895,308 B1Massachusetts Institute of Technology · 2014
- Hybrid adenovirus-AAV virus and methods of use thereof311US 5,871,982 AThe Trustees of the University of Pennsylvania · 1999